PlegridyPen (Biogen Inc.)


Welcome to the PulseAid listing for the Plegridy drug offered from Biogen Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Biogen Inc.
NON-PROPRIETARY NAME: peginterferon beta-1a
SUBSTANCE NAME: PEGINTERFERON BETA-1A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2014-08-15
END MARKETING DATE: 0000-00-00


Plegridy Pen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPlegridy Pen from Biogen Inc.
LABELER NAME: Biogen Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 125(ug/.5mL)
START MARKETING DATE: 2014-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64406-011_08a37cde-f349-4bed-993d-e21934a5fb71
PRODUCT NDC: 64406-011
APPLICATION NUMBER: BLA125499

Other PEGINTERFERON BETA-1A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Biogen Inc.Plegridy